Q linea

Q linea ROCE

The Return on Capital Employed (ROCE) of Q linea (QLINEA.ST) as of Nov 3, 2026 is -52.27 %. In the previous year, Return on Capital Employed (ROCE) was 776.39 % — a change of -106.73% (lower).

ROCE

-52.27 %

YoY

-106.73%

Last updated:

In 2025, Q linea's return on capital employed (ROCE) was -52.27 %, a -106.73% increase from the 776.39 % ROCE in the previous year.

The Q linea ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2018
-24.81 SEK
Jan 1, 2019
-52.53 SEK
Jan 1, 2020
-58.27 SEK
Jan 1, 2021
-54.21 SEK
Jan 1, 2022
-162.25 SEK
Jan 1, 2023
-121.59 SEK
Jan 1, 2024
776.39 SEK
Jan 1, 2025
-52.27 SEK
The Q linea ROCE history
YEARROCEYoY
-52.27 %-106.73%
776.39 %-738.51%
-121.59 %-25.06%
-162.25 %+199.28%
-54.21 %-6.96%
-58.27 %+10.92%
-52.53 %+111.79%
-24.81 %-99.45%
-4,489.29 %+531.66%
-710.72 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Q linea Stock analysis

What does Q linea do? Q-linea AB develops and manufactures in-vitro diagnostic solutions for infectious diseases, focusing on antibiotic susceptibility testing. The company's core product, ASTar, is a fully-automated instrument that provides susceptibility profiles within three to six hours directly from positive blood cultures. This enables early targeted antibiotic administration for sepsis identification in hospital patients, primarily serving hospital laboratories. The firm measures bacteria's antimicrobial susceptibility using its own disposables, which are integral to the ASTar system's operation. Q-linea AB's revenue model is based on selling the ASTar instrument and its associated disposables to hospital laboratories. The company's product is specifically designed for sepsis identification in hospital settings, where rapid and accurate antibiotic susceptibility testing is critical. By providing a faster solution than traditional methods, Q-linea targets hospital labs seeking to improve patient outcomes in sepsis cases. The company operates as a holding company with a focus on developing and manufacturing IVD solutions. Its primary customers are hospital laboratories, which purchase the ASTar system and disposables to streamline their diagnostic processes. The firm's business model centers on the sale of both the instrument and the consumable disposables, creating recurring revenue streams from ongoing disposables usage. Q linea is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Q linea's Return on Capital Employed (ROCE)

Q linea's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Q linea's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Q linea's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Q linea’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Q linea stock

Return on Capital Employed (ROCE) of Q linea is -52.27 % in 2025.

Return on Capital Employed (ROCE) of Q linea changed from 776.39 % to -52.27 %, representing a -106.73% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Q linea since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Q linea with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Q linea

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Q linea